etoposide has been researched along with mocetinostat in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, B; Chen, Y; Huang, Q; Li, J; Lu, W; Luo, Y; Sheng, L; Su, M; Tong, L; Yang, B; Yu, X; Zhang, X; Zhu, H | 1 |
| Harada, H; Higuchi, T; Maeda, T; Miyoshi, Y; Mori, H; Niikura, H; Okada, S; Shimizu, T; Tada, J; Takahashi, N | 1 |
| Borisenko, GG; Fabisiak, JP; Kagan, VE; Thampatty, P; Tyurin, VA; Tyurina, YY; Yalowich, JC | 1 |
| Kagan, VE; Kuzmenko, AI; Matsura, T; Shvedova, AA; Tyurina, YY; Yalowich, JC | 1 |
| Akiyama, H; Asou, N; Kiyoi, H; Kodera, Y; Kuriyama, K; Kusumoto, S; Miyawaki, S; Motoji, T; Naoe, T; Nishimura, M; Ohno, R; Saito, H; Saito, K; Shimazaki, C; Shinagawa, K; Tagawa, Y; Ueda, R | 1 |
| Furuta, GT; Glickman, J; Köhler, H; Nurko, S | 1 |
| Basova, LV; Belikova, NA; Kagan, VE; Kapralov, AA; Kurnikov, IV; Osipov, AN; Peterson, J; Potapovich, MV; Tyurin, VA; Vladimirov, YA | 1 |
| Day, BW; Fan, Y; Giorgianni, A; Schreiber, EM; Yalowich, JC | 1 |
| Cierniak, A; Elas, M; Kapiszewska, M; Lankoff, A | 1 |
| Caracciolo, F; Focosi, D; Galimberti, S; Papineschi, F; Petrini, M | 1 |
| Basova, LV; Bayir, H; Belikova, NA; Jiang, J; Kagan, VE; Kapralov, AA; Kurnikov, IV; Tyurin, VA; Tyurina, YY; Vladimirov, YA; Vlasova, II; Zhao, Q | 1 |
| Do, D; Feng, WH; Giorgianni, A; Goff, JP; Gollin, SM; Kagan, VE; Lewis, DW; Vlasova, II; Yalowich, JC | 1 |
| Krzyściak, W; Papież, MA | 1 |
| Atwal, M; Austin, CA; Cowell, IG; Lishman, EL | 1 |
1 review(s) available for etoposide and mocetinostat
| Article | Year |
|---|---|
Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature.
Topics: Adult; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 21; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Iodide Peroxidase; Leukemia, Myeloid, Acute; Peroxidase; Propylthiouracil; Remission Induction; Time Factors; Translocation, Genetic; Transplantation, Homologous | 2008 |
1 trial(s) available for etoposide and mocetinostat
| Article | Year |
|---|---|
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Follow-Up Studies; Gene Deletion; Genotype; Glutathione Transferase; Humans; Isoenzymes; Leukemia, Myeloid; Mercaptopurine; Multivariate Analysis; NAD(P)H Dehydrogenase (Quinone); Neoplasm Proteins; Peroxidase; Polymorphism, Genetic; Prednisolone; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome | 2002 |
12 other study(ies) available for etoposide and mocetinostat
| Article | Year |
|---|---|
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
Topics: DNA Topoisomerases, Type II; Drug Evaluation, Preclinical; Enzyme Activation; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Phenylenediamines; Podophyllotoxin; Recombinant Proteins; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vorinostat | 2013 |
[Cytological features and prognosis of megakaryoblastic leukemia].
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Histocytochemistry; Humans; Infant; Male; Methotrexate; Microscopy, Electron; Middle Aged; Nitrosourea Compounds; Peroxidase; Prednisolone; Prognosis; Thrombocythemia, Essential; Vincristine | 1994 |
Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach.
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Antioxidants; Ascorbic Acid; Chromans; DNA Topoisomerases, Type II; DNA, Neoplasm; Electrons; Etoposide; Free Radicals; HL-60 Cells; Humans; Hydrogen Peroxide; Leukemia, Myeloid; Oxidation-Reduction; Peroxidase; Phospholipids; Sulfhydryl Compounds; Vitamin E | 1999 |
Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Biotransformation; DNA Topoisomerases, Type II; DNA, Neoplasm; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; HL-60 Cells; Humans; Hydrogen Peroxide; Lipid Peroxidation; Oxidation-Reduction; Peroxidase; Phenols; Phospholipids; Reactive Oxygen Species | 2001 |
Acute myeloid leukemia presenting as non-neutropenic colitis in an infant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colitis; Colon; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Immunohistochemistry; Infant; Leukemia, Myeloid, Acute; Leukemic Infiltration; Leukocyte Common Antigens; Peroxidase; Sigmoidoscopy; Thioguanine | 2003 |
Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes.
Topics: Acridine Orange; Animals; Binding, Competitive; Cardiolipins; Cell Membrane; Cytochromes c; Electrophoresis; Enzyme Activation; Etoposide; Fluoresceins; Horses; Hydrophobic and Hydrophilic Interactions; Lipids; Liposomes; Osmolar Concentration; Oxidation-Reduction; Peroxidase; Phosphatidylcholines; Spectrometry, Fluorescence; Structure-Activity Relationship; Time Factors; Tryptophan | 2006 |
Myeloperoxidase-catalyzed metabolism of etoposide to its quinone and glutathione adduct forms in HL60 cells.
Topics: Benzoquinones; Catalysis; Chromatography, Liquid; DNA Adducts; Etoposide; Glutathione; HL-60 Cells; Humans; Mass Spectrometry; Peroxidase | 2006 |
Lifespan of etoposide-treated human neutrophils is affected by antioxidant ability of quercetin.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; DNA Damage; Etoposide; Humans; Hydrogen Peroxide; Neutrophils; Peroxidase; Phenols; Quercetin; Reactive Oxygen Species | 2007 |
The hierarchy of structural transitions induced in cytochrome c by anionic phospholipids determines its peroxidase activation and selective peroxidation during apoptosis in cells.
Topics: Animals; Apoptosis; Cardiolipins; Cytochromes c; Electron Spin Resonance Spectroscopy; Enzyme Activation; Etoposide; Fluorescence; Heme; Humans; Mice; Peroxidase; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylserines; Phospholipids; Protein Structure, Tertiary; Tryptophan | 2007 |
Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells.
Topics: Antigens, CD34; Antineoplastic Agents, Phytogenic; Comet Assay; Electron Spin Resonance Spectroscopy; Etoposide; Flow Cytometry; Gene Rearrangement; Guaiacol; Humans; Immunoblotting; Myeloid Progenitor Cells; Oxidation-Reduction; Peroxidase | 2011 |
The antioxidant quercetin protects HL-60 cells with high myeloperoxidase activity against pro-oxidative and apoptotic effects of etoposide.
Topics: Antioxidants; Apoptosis; Etoposide; HL-60 Cells; Humans; Oxidation-Reduction; Peroxidase; Quercetin; Reactive Oxygen Species | 2014 |
Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cytoprotection; DNA; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; Glutathione; Histones; Humans; Mitoxantrone; Myeloid Cells; Neoplasms; Peroxidase; Phosphorylation; Poly-ADP-Ribose Binding Proteins; Small Molecule Libraries | 2017 |